Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Completion of the Updated Caprini Risk Assessment Model (2013 Version).
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund.
Reframing Financial Incentives Around Reducing Readmission After Radical Cystectomy.
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors.
The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease. Inflamm Bowel Dis. 2018 02 15; 24(3):502-509.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal, Humanized
Crohn Disease
Female
Gastrointestinal Agents
Humans
Male
Middle Aged
Postoperative Period
Propensity Score
Recurrence
Remission Induction
Retrospective Studies
Secondary Prevention
Tumor Necrosis Factor-alpha
Young Adult
authors with profiles
David T. Rubin
Joel R. Pekow
Konstantin Umanskiy
Russell D. Cohen
Sushila R. Dalal